Unlike adiponectin, plasma leptin levels are increased in obesity and type 2 diabetes, reflecting a state of leptin resistance; and are independently associated with hypoadiponectinemia, insulin resistance, dyslipidemia, inflammatory markers, and CVD [4]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.